Rx/Reimbursement Adult Incontinence in Australia
The Australian government introduced the National Continence Program in 2011 to build on goals that were previously achieved by the National Continence Management Strategy. The main goals of the initiative included increasing public awareness about the issue of adult incontinence, educating those affected about how to manage their condition and where to seek help and to improve and facilitate access to quality incontinence care. The programme was developed as a “whole of life” programme and iden...
Euromonitor International's Rx/Reimbursement adult incontinence in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2013-2017, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2022 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
- RX/REIMBURSEMENT ADULT INCONTINENCE IN AUSTRALIA
- Euromonitor International
- April 2018
- LIST OF CONTENTS AND TABLES
- Australian Government To Focus on Education
- Payment Scheme To Provide Assistance To Those Eligible
- Number of People Suffering From Incontinence Expected To Rise
- Category Data
- Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2012-2017
- Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2012-2017
- Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2017-2022
- Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2017-2022
- Executive Summary
- Tissue and Hygiene Growth Remains Steady in Australia
- Retail Incontinence To See the Strongest Growth
- Major Supermarkets Dominate Distribution
- Private Label To Continue Growth
- Major Players Continue To Dominate the Market
- Market Indicators
- Table 5 Birth Rates 2012-2017
- Table 6 Infant Population 2012-2017
- Table 7 Female Population by Age 2012-2017
- Table 8 Total Population by Age 2012-2017
- Table 9 Households 2012-2017
- Table 10 Forecast Infant Population 2017-2022
- Table 11 Forecast Female Population by Age 2017-2022
- Table 12 Forecast Total Population by Age 2017-2022
- Table 13 Forecast Households 2017-2022
- Market Data
- Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2012-2017
- Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2012-2017
- Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2013-2017
- Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2014-2017
- Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2012-2017
- Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2012-2017
- Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2017
- Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2017-2022
- Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2017-2022
- Summary 1 Research Sources